Highly active antiretroviral therapy dysregulates proliferation and differentiation of human pre-adipocytes.

about

Highly active antiretroviral therapy dysregulates proliferation and differentiation of human pre-adipocytes.

Item

http://www.wikidata.org/entity/Q41450474

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Highly active antiretroviral t ...... ation of human pre-adipocytes.

@en

type

Item

label

Highly active antiretroviral t ...... ation of human pre-adipocytes.

@en

prefLabel

Highly active antiretroviral t ...... ation of human pre-adipocytes.

@en

P1476

Highly active antiretroviral t ...... ation of human pre-adipocytes.

@en

P2093

Eyone Jones

http://www.w3.org/2001/XMLSchema#string

Frank Darras

http://www.w3.org/2001/XMLSchema#string

Giuseppe Caso

http://www.w3.org/2001/XMLSchema#string

Margaret A McNurlan

http://www.w3.org/2001/XMLSchema#string

Marie C Gelato

http://www.w3.org/2001/XMLSchema#string

Pavel Mazirka

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of ritonavir and atazanavir on human subcutaneous preadipocyte proliferation and differentiation.

Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients.

HIV-associated lipodystrophy: impact of antiretroviral therapy.

HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy.

Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.

Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.

"One pill, once daily": what clinicians need to know about Atriplatrade mark.

Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.

In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes.

Tumour cell growth in culture: dependence on arginine.

P304

53-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5501/WJV.V6.I3.53

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28868243

http://www.w3.org/2001/XMLSchema#string

P932

5561499

http://www.w3.org/2001/XMLSchema#string